On 9th February 2019, the EU Falsified Medicines Directive (FMD) will come into force. Among the many challenges it brings, it will require manufacturers to serialise their products, register with the European Medicines Verification Organisation and to upload all product and pack data to the European Medicines Verification System.
tracekey is a solution that has been developed with small to medium sized organisations in mind – a single-source solution for complying with all legal requirements of serialisation.
Join us for a webinar on any one of three dates to get an understanding of the FMD requirements, see a demo of our solution and have the opportunity to raise any questions you may have with our experts.
David Doyle, IT Project Manager, Irish Medicines Verification Organisation (IMVO), will discuss the EU Falsified Medicines Directive (EUFMD) and what it means for your business.
Stefan Hoffman, Managing Director, tracekey will give an overview of the solution and how it can be implemented quickly and efficiently for small to medium sized pharmaceutical companies.
If you would like further information please get in touch.
tracekey is the ideal partner for making your pharma business resilient. We are IT-specialists offering you a cost-efficient, single-source solution to meet the requirements of the Falsified Medicines Directive. BearingPoint has invested in tracekey and is also it’s leading implementation partner.